Literature DB >> 11953392

Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae.

Priya Balachandran1, Alexis Brooks-Walter, Anni Virolainen-Julkunen, Susan K Hollingshead, David E Briles.   

Abstract

Previous studies suggested that PspC is important in adherence and colonization within the nasopharynx. In this study, we conducted mutational studies to further identify the role PspC plays in the pathogenesis of pneumococci. pspC and/or pspA was insertionally inactivated in a serotype 2 Streptococcus pneumoniae strain and in a serotype 19 S. pneumoniae strain. In the mouse colonization model, pneumococcal strains with mutations in pspC were significantly attenuated in their abilities to colonize. In a mouse pneumonia model, strains with mutations in pspC were unable to infect or multiply within the lung. Using reverse transcriptase PCR we were able to demonstrate that pspC is actively transcribed in vivo, when the bacteria are growing in the nasal cavity and in the lungs. In the bacteremia model, a strain mutated for pspC alone behaved like the wild type, but the absence of both pspC and pspA caused accelerated clearance of the bacteria. Intranasal immunization with PspC with cholera toxin subunit B as an adjuvant protected against intranasal challenge. Evidence was also obtained that revertants that spontaneously acquired PspC expression could multiply and colonize the nasal tissue. This latter finding strongly indicates that pneumococci are actively metabolizing and growing while in the nasopharynx.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953392      PMCID: PMC127914          DOI: 10.1128/IAI.70.5.2526-2534.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  46 in total

1.  Molecular localization of variable and conserved regions of pspA and identification of additional pspA homologous sequences in Streptococcus pneumoniae.

Authors:  L S McDaniel; J S Sheffield; E Swiatlo; J Yother; M J Crain; D E Briles
Journal:  Microb Pathog       Date:  1992-10       Impact factor: 3.738

2.  Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene.

Authors:  J Yother; G L Handsome; D E Briles
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

3.  Relationship between colonial morphology and adherence of Streptococcus pneumoniae.

Authors:  D R Cundell; J N Weiser; J Shen; A Young; E I Tuomanen
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

4.  Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae.

Authors:  C Rosenow; P Ryan; J N Weiser; S Johnson; P Fontan; A Ortqvist; H R Masure
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

5.  Characterization of binding of human lactoferrin to pneumococcal surface protein A.

Authors:  A Håkansson; H Roche; S Mirza; L S McDaniel; A Brooks-Walter; D E Briles
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  PspC, a pneumococcal surface protein, binds human factor H.

Authors:  S Dave; A Brooks-Walter; M K Pangburn; L S McDaniel
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae.

Authors:  S Hammerschmidt; G Bethe; P H Remane; G S Chhatwal
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

8.  SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component.

Authors:  S Hammerschmidt; S R Talay; P Brandtzaeg; G S Chhatwal
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

9.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

Authors:  H Y Wu; M H Nahm; Y Guo; M W Russell; D E Briles
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

10.  Requirement for capsule in colonization by Streptococcus pneumoniae.

Authors:  A D Magee; J Yother
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

View more
  83 in total

1.  Inhibition of pneumococcal adherence to human nasopharyngeal epithelial cells by anti-PsaA antibodies.

Authors:  Sandra Romero-Steiner; Tamar Pilishvili; Jacquelyn S Sampson; Scott E Johnson; Annie Stinson; George M Carlone; Edwin W Ades
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

Review 2.  Next generation pneumococcal vaccines.

Authors:  Kristin L Moffitt; Richard Malley
Journal:  Curr Opin Immunol       Date:  2011-04-21       Impact factor: 7.486

3.  PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected].

Authors:  Mirza Shaper; Susan K Hollingshead; William H Benjamin; David E Briles
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Pneumococcal interactions with epithelial cells are crucial for optimal biofilm formation and colonization in vitro and in vivo.

Authors:  Laura R Marks; G Iyer Parameswaran; Anders P Hakansson
Journal:  Infect Immun       Date:  2012-05-29       Impact factor: 3.441

5.  Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization.

Authors:  Lance E Keller; Xiao Luo; Justin A Thornton; Keun-Seok Seo; Bo Youn Moon; D Ashley Robinson; Larry S McDaniel
Journal:  Clin Vaccine Immunol       Date:  2015-08-26

6.  Serine protease PrtA from Streptococcus pneumoniae plays a role in the killing of S. pneumoniae by apolactoferrin.

Authors:  Shaper Mirza; Landon Wilson; William H Benjamin; Jan Novak; Stephen Barnes; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2011-03-21       Impact factor: 3.441

7.  Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.

Authors:  Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Senthil Kumar K Sakthivel; Edwin W Ades; David E Briles; Susan K Hollingshead; James C Paton; Jacquelyn S Sampson; James W Lillard
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Mn2+-dependent regulation of multiple genes in Streptococcus pneumoniae through PsaR and the resultant impact on virulence.

Authors:  Jason W Johnston; David E Briles; Lisa E Myers; Susan K Hollingshead
Journal:  Infect Immun       Date:  2006-02       Impact factor: 3.441

Review 9.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

10.  Staphylococcus aureus elicits marked alterations in the airway proteome during early pneumonia.

Authors:  Christy L Ventura; Roger Higdon; Laura Hohmann; Daniel Martin; Eugene Kolker; H Denny Liggitt; Shawn J Skerrett; Craig E Rubens
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.